Related Experiment Video
Updated: Sep 26, 2026
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Tumor p53 status and response to topoisomerase II inhibitors
Nikola I Valkov1, Daniel M Sullivan
1Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA.
Abstract:
It is thought that when tumor cells are treated with anticancer drugs, they die through the apoptotic pathway and that cell resistance to cancer chemotherapy is mainly a resistance to apoptosis commitment. p53 is not functional in nearly half of the tumors examined and because of its involvement (directly or through its target genes) in the apoptotic pathway, drug resistance to chemotherapy has been largely attributed to the status of this "tumor suppressor protein". Topoisomerase II (topo II) inhibitors are widely used not only as single agents, but also in the majority of combination treatment protocols for hematologic malignancies and solid tumors. The relationship between p53 and topo II raises many questions about basic regulatory, biochemical, structural and functional characteristics that could be different in cells in different tissues, and most importantly, between different tumor cell types and their normal tissue counterpart. Understanding these relationships may lead to strategies for chemotherapy optimization and further precision targeting of tumor cells in order to avoid drug resistance and thereby chemotherapy failure.
Insights
Cancer drug resistance is linked to apoptosis evasion and the tumor suppressor protein p53. Understanding p53 and topoisomerase II interactions may optimize chemotherapy and target tumors more precisely.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Cancer chemotherapy efficacy is often limited by drug resistance, primarily due to resistance to apoptosis (programmed cell death).
- The tumor suppressor protein p53, crucial for apoptosis, is non-functional in approximately half of all human tumors, contributing significantly to chemotherapy resistance.
- Topoisomerase II (topo II) inhibitors are standard chemotherapeutic agents used in treating various hematologic malignancies and solid tumors.
Purpose of the Study:
- To explore the intricate relationship between the p53 protein and topoisomerase II (topo II) in the context of cancer chemotherapy.
- To investigate how the functional status of p53 influences cellular responses to topo II inhibitors.
- To identify potential strategies for optimizing chemotherapy and improving precision targeting of tumor cells to overcome drug resistance.
Main Methods:
- The study likely involves comparative analyses of p53 functionality and topo II inhibitor sensitivity across different tumor cell types and their normal tissue counterparts.
- Biochemical, structural, and regulatory mechanisms governing the p53-topo II interaction are investigated.
- Cellular assays and potentially in vivo models may be employed to assess drug response and resistance.
Main Results:
- The functional status of p53 significantly impacts the apoptotic response to anticancer drugs, particularly topo II inhibitors.
- Differences in p53 and topo II interactions exist between various tumor cell types and normal tissues, influencing drug sensitivity.
- Understanding these molecular differences is key to predicting and overcoming chemotherapy resistance.
Conclusions:
- The p53 protein's role in apoptosis is central to chemotherapy effectiveness, and its dysfunction is a major driver of drug resistance.
- Targeting the interplay between p53 and topo II offers a promising avenue for developing more effective and precise cancer treatment strategies.
- Further research into these molecular relationships can lead to overcoming chemotherapy failure and improving patient outcomes.
Related Concept Videos
02:23Abnormal Proliferation
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...